Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment
about
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an updateInterferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysisInsight into the diagnosis and management of subclinical genital tuberculosis in women with infertilityCorrelation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingResponse to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response.T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosisIP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals.Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area.Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis.Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected childrenSensitivity of the quantiferon-gold in-tube assay in sputum smear positive TB cases in Indonesia.Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.The immunology of tuberculosis: from bench to bedside.Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapyDiscriminating between latent and active tuberculosis with multiple biomarker responses.Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosisCombined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in miceReproducibility of QuantiFERON-TB gold in-tube assay.Current issues on molecular and immunological diagnosis of tuberculosis.Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response.Update in tuberculosis 2007.Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis.How flow cytometry is changing the study of TB immunology and clinical diagnosis.Detection and diagnosis of Mycobacterium tuberculosis.Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis.The role of interferon-gamma release assay in tuberculosis control.Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment.QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia.
P2860
Q22241138-8D6FCF46-33F1-4358-B285-BCAC7734FE53Q22242874-381E7FC7-4037-430F-B599-4AD43FB1E995Q28075513-E4B73FF0-EC0B-4EF9-B068-7ED1757141AEQ28729742-434E0951-864F-44BE-9575-1E46F12AC0DEQ30840526-E1D8DCDC-A25E-43E5-BA47-F48960471ECBQ30979334-956CB747-DAF6-479B-A34C-784657A02FA8Q33293104-6C54B626-6BA0-4BBB-9169-E79E13DB615DQ33295392-C694EFC5-4D12-4959-9BF0-42080AEEA932Q33325475-0B804077-8517-4344-AF39-413FFFA8798DQ33344474-0E7A09F7-31DD-46C7-AECA-5238C4E796A9Q33358065-27C93027-BD94-4C34-9A18-3DAA64B84AA0Q33401266-4955C929-121C-4928-8968-EC176B099175Q33405619-7FEDEE60-EBC8-4D1F-8341-6ABA8A56DEA3Q33429956-0DECB68E-A1B9-4F61-9B6C-8A4BE5FB5491Q33455753-BA94F769-B68D-45B6-8316-3E65A7E39B99Q33477971-66590741-1774-47DA-9742-95B4BB2B91F3Q33530113-300460B9-8B04-4F52-B846-AFC84366AA9AQ33589272-F5D73483-5564-4ED1-802D-C6AD9F1FC8F1Q33658539-1CEDD25D-0327-4881-BC1C-5C1349FB1B9CQ33719971-28B9BAE1-205F-45FD-A6C6-FADC941D4830Q33777367-061AA381-6DC4-4692-9478-1BC87DBC86A3Q33807147-E031DECC-5F55-4999-88FF-869AB7D120ABQ33905874-04501A98-2374-41A0-8160-65B5FD15AA49Q34958633-1CA804D1-7769-4605-B724-88AEB9BCDF31Q35138740-AD237138-1006-44ED-B4B2-9C907B7C3E60Q35192333-188273B5-D045-43C0-BADB-FEBE13323719Q36497632-C3A8C482-A948-48FC-AFF1-2848418A21F2Q36497683-8C99CE2B-AF31-4707-8E7A-699C42FC778CQ36861562-5667C3AE-568B-4970-B9AE-E2BED748249BQ37081488-B9A4DEE0-B1EE-40DA-883A-CAB12CC10E41Q37093439-1E8B8E57-8B39-4706-87EB-8C27B108C852Q37116521-3AF177EC-A509-45E4-AD90-B28606338EA7Q37238441-F09EDD44-7982-482F-9EA3-07342F3728C4Q37626065-BD3FE8F2-4596-44E6-A9B4-AAB61761E45CQ37724458-9E25A6C0-AD89-40A9-A013-20E35860BED0Q37997253-119C4C87-34EC-46E0-A363-5EDF563002A2Q39036474-18F2137A-6E30-41BE-8BFD-8DF20CC2A0C3Q54214232-F531CCDF-D21C-4C72-A813-BF1005DFFBD3
P2860
Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@ast
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@en
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@nl
type
label
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@ast
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@en
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@nl
prefLabel
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@ast
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@en
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@nl
P2093
P2860
P50
P1433
P1476
Sensitivity of a whole-blood i ...... ng anti-tuberculosis treatment
@en
P2093
M Bandyopadhyay
S Kalantri
P2860
P2888
P304
P356
10.1007/S15010-007-6114-Z
P577
2007-04-01T00:00:00Z
P5875
P6179
1039438617